Competition

Drugs may compete for binding with plasma proteins leading to interactions. This is significant for highly bound drugs such as the anticoagulant warfarin since even a small change in binding will greatly affect the amount of free drug.

Such an effect is produced by the concurrent administration of aspirin, which displaces warfarin and increases the amount of free anticoagulant.